Vladimer Darsalia Selected Research

Glucagon-Like Peptide-1 Receptor

2/2022	Normalisation of glucose metabolism by exendin-4 in the chronic phase after stroke promotes functional recovery in male diabetic mice.
1/2018	Glucagon-like receptor 1 agonists and DPP-4 inhibitors: Anti-diabetic drugs with anti-stroke potential.
2/2016	Type 2 diabetes-induced neuronal pathology in the piriform cortex of the rat is reversed by the GLP-1 receptor agonist exendin-4.
5/2015	Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke.
5/2012	Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vladimer Darsalia Research Topics

Disease

27	Stroke (Strokes) 02/2022 - 06/2003
18	Type 2 Diabetes Mellitus (MODY) 02/2022 - 05/2012
4	Atrophy 02/2022 - 01/2019
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021 - 06/2003
3	Insulin Resistance 02/2022 - 10/2021
3	Neuroinflammatory Diseases 12/2021 - 01/2014
3	Hyperglycemia 11/2020 - 01/2018
3	Cognitive Dysfunction 11/2020 - 12/2016
3	Parkinson Disease (Parkinson's Disease) 01/2020 - 12/2010
2	Brain Injuries (Brain Injury) 01/2021 - 01/2014
2	Obesity 01/2019 - 04/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 12/2006
2	Ischemic Stroke 01/2018 - 09/2011
1	Cicatrix (Scar) 02/2022
1	Weight Loss (Weight Reduction) 12/2021
1	Ischemia 01/2021
1	Weight Gain 11/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Brain Diseases (Brain Disorder) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Inflammation (Inflammations) 01/2018
1	Thrombosis (Thrombus) 01/2018
1	Nervous System Diseases (Neurological Disorders) 09/2014
1	Body Weight (Weight, Body) 04/2013
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2013
1	Chorea (Rheumatic Chorea) 06/2003

Drug/Important Bio-Agent (IBA)

8	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018 - 04/2013
6	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 04/2013
5	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2022 - 04/2013
5	Glucagon-Like Peptide-1 ReceptorIBA 02/2022 - 05/2012
5	LinagliptinIBA 01/2019 - 04/2013
5	Neuroprotective AgentsIBA 05/2015 - 05/2012
4	ParvalbuminsIBA 12/2021 - 06/2003
3	Exenatide (Byetta)FDA Link 02/2022 - 01/2014
3	Glucagon-Like Peptide ReceptorsIBA 01/2018 - 01/2014
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 09/2014 - 05/2014
2	Pharmaceutical PreparationsIBA 05/2012 - 12/2010
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 02/2022
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 01/2021
1	AR-R 17779IBA 01/2021
1	SugarsIBA 11/2020
1	Indicators and Reagents (Reagents)IBA 11/2020
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2020
1	Myelin Basic ProteinIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	NeurograninIBA 01/2018
1	Aminobutyrates (Aminobutyric Acid)IBA 12/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2014
1	Peptide Hydrolases (Proteases)FDA Link 09/2014
1	CytokinesIBA 01/2014
1	GalaninIBA 10/2013
1	Lys(15)-Arg(16)-Leu(27)- vasoactive intestinal peptide (1-7)-GRF (8-27)IBA 04/2013
1	glimepiride (Amarel)FDA LinkGeneric 04/2013
1	Type II Vasoactive Intestinal Peptide ReceptorsIBA 04/2013
1	Insulin-Like PeptidesIBA 04/2012
1	PlasticsIBA 04/2012
1	Transcription Factors (Transcription Factor)IBA 04/2012
1	Proteins (Proteins, Gene)FDA Link 04/2012
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 04/2012
1	Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 04/2012
1	Dopamine (Intropin)FDA LinkGeneric 12/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2008
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 09/2008
1	CaspasesIBA 03/2006
1	gamma-Aminobutyric Acid (GABA)IBA 06/2003
1	Green Fluorescent ProteinsIBA 06/2003
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2003
1	Cholinergic Agents (Cholinergics)IBA 06/2003
1	Neuropeptide YIBA 06/2003

Therapy/Procedure

7	Therapeutics 01/2019 - 12/2006
4	Transplantation 01/2018 - 08/2007
2	Stem Cell Transplantation 01/2018 - 09/2011
1	Activities of Daily Living (ADL) 01/2019
1	Thrombectomy 01/2018